HotCopper Trends: Resolution Minerals, scandium hits, Paradigm Biopharma and more
AppleApple(US:AAPL) The Market Online·2026-02-09 02:38

Group 1 - Resolution Minerals has announced a new gold discovery at its Golden Gate South acreage and is progressing towards a NASDAQ listing [4] - Paradigm Biopharmaceuticals is pivoting into the animal care sector, with its osteoarthritis drug candidate currently being tested in oral form on animals [4] - Australian Mines Ltd reported exceptional scandium grades at its Flemington asset, leading to a 9% increase in shares to 1.8 cents per share [4] - New Age Exploration is under a trading halt while anticipating positive drilling results at the Wagyu Gold Project [4] - Dreadnought Resources reported further high-grade gold discoveries at its Mangaroon project [4] - Memphasys received approval from the Australian drug regulator TGA for its Felix technology aimed at the IVF market, resulting in a 27% share price increase, with shares at 0.7 cents per share [4]